Mission Pharmacal sponsored a survey that was conducted by Inspire with the National Osteoporosis Foundation (NOF) support online community.1
When women with osteoporosis were asked what they liked and disliked about taking their osteoporosis medicine, they spoke out. Swallowing pills or tablets is an issue for more women than one might think.
Some 82% of the survey respondents had been diagnosed with osteoporosis, and 73% had taken or were currently taking osteoporosis medicine in a pill or tablet form.
Their responses paint a clear picture about dosing preferences for osteoporosis medicine.
A total of 331 women participated in the survey; 291 of them had been diagnosed with osteoporosis. The survey was conducted in June and July of 2013.
If you have difficulty swallowing or would simply prefer liquid instead of a pill or tablet, let your health care professional know. There are alternatives, including BINOSTO® (alendronate sodium) effervescent tablet for oral solution 70 mg.
BINOSTO® supports osteoporosis patients with a valuable savings card. When you present the card to the pharmacist, you will receive up to $60 off on each of your prescriptions for a total of $720 per year.